672 related articles for article (PubMed ID: 25251899)
21. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
22. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
23. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
24. RNA interference-mediated simultaneous silencing of four genes using cross-shaped RNA.
Lee TY; Chang CI; Lee D; Hong SW; Shin C; Li CJ; Kim S; Haussecker D; Lee DK
Mol Cells; 2013 Apr; 35(4):320-6. PubMed ID: 23563800
[TBL] [Abstract][Full Text] [Related]
25. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
26. Alkane-modified short polyethyleneimine for siRNA delivery.
Schroeder A; Dahlman JE; Sahay G; Love KT; Jiang S; Eltoukhy AA; Levins CG; Wang Y; Anderson DG
J Control Release; 2012 Jun; 160(2):172-6. PubMed ID: 22155553
[TBL] [Abstract][Full Text] [Related]
27. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers.
Sahin B; Fife J; Parmar MB; Valencia-Serna J; Gul-Uludağ H; Jiang X; Weinfeld M; Lavasanifar A; Uludağ H
Biomaterials; 2014 Nov; 35(34):9382-94. PubMed ID: 25128374
[TBL] [Abstract][Full Text] [Related]
28. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
29. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
30. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
[TBL] [Abstract][Full Text] [Related]
32. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
33. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
34. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
35. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.
Duan J; Dong J; Zhang T; Su Z; Ding J; Zhang Y; Mao X
Nanomedicine (Lond); 2014 May; 9(6):789-801. PubMed ID: 24392891
[TBL] [Abstract][Full Text] [Related]
36. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
Lee SH; Chung BH; Park TG; Nam YS; Mok H
Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
[TBL] [Abstract][Full Text] [Related]
37. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
38. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.
Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG
J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409
[TBL] [Abstract][Full Text] [Related]
39. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K
Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]